Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds

<div>(a) Structure of the SARS-CoV-2 protease cocrystallised with the inhibitor N<sub>3</sub>. (b) Sequence of amino acids in the protease.</div>

Advances in Pharmacological and Pharmaceutical Sciences

fig1

Figure 1

Figure 1: Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds 

Figure 1 | Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds 